An IRF5 risk haplotype is associated to a high serum IFN-α activity in patients and especially in those with autoantibodies to RNA-binding proteins or double-stranded DNA (71), linking SLE genetic susceptibility to the presence of interferogenic ICs. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.